LEI-106

Customer Review

Based on 1 Customer Validation

LEI-106 is a dual ABHD6 and DAGL-α inhibitor, with a Ki of 0.8 μM for ABHD6, and an IC50 of 18 nM and a Ki of 0.7 μM for DAGL-α. LEI-106 blocks the synthesis of 2-arachidonoylglycerol, reduces the level of endothelial cell-derived 2-arachidonoylglycerol, without altering the levels of cannabinoids and diacylglycerol. LEI-106 is applicable to research related to diet-induced obesity and metabolic syndrome.

For research use only. We do not sell to patients.

  • Purity: 98.86%
  • CAS No.: 1620582-23-1
  • Formula: C26H27NO6S
  • Molecular Weight:481.56
  • Storage:
    Powder   -20°C, 3 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs

All DAGL Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00